These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18448869)

  • 1. An aberrant protein complex in CSF as a biomarker of Alzheimer disease.
    Lovell MA; Lynn BC; Xiong S; Quinn JF; Kaye J; Markesbery WR
    Neurology; 2008 Jun; 70(23):2212-8. PubMed ID: 18448869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Plasma Based Biomarker of Alzheimer's Disease.
    Bradley-Whitman MA; Abner E; Lynn BC; Lovell MA
    J Alzheimers Dis; 2015; 47(3):761-71. PubMed ID: 26401710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced levels of amyloid-beta-binding proteins in cerebrospinal fluid from Alzheimer's disease patients.
    Hansson SF; Andréasson U; Wall M; Skoog I; Andreasen N; Wallin A; Zetterberg H; Blennow K
    J Alzheimers Dis; 2009; 16(2):389-97. PubMed ID: 19221428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease.
    Zetterberg H; Andreasson U; Hansson O; Wu G; Sankaranarayanan S; Andersson ME; Buchhave P; Londos E; Umek RM; Minthon L; Simon AJ; Blennow K
    Arch Neurol; 2008 Aug; 65(8):1102-7. PubMed ID: 18695061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential post-translational modifications of transthyretin in Alzheimer's disease: a study of the cerebral spinal fluid.
    Biroccio A; Del Boccio P; Panella M; Bernardini S; Di Ilio C; Gambi D; Stanzione P; Sacchetta P; Bernardi G; Martorana A; Federici G; Stefani A; Urbani A
    Proteomics; 2006 Apr; 6(7):2305-13. PubMed ID: 16552785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease.
    Lee JW; Namkoong H; Kim HK; Kim S; Hwang DW; Na HR; Ha SA; Kim JR; Kim JW
    BMC Neurol; 2007 Jun; 7():14. PubMed ID: 17565664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CSF cortisol in Alzheimer's disease and mild cognitive impairment.
    Popp J; Schaper K; Kölsch H; Cvetanovska G; Rommel F; Klingmüller D; Dodel R; Wüllner U; Jessen F
    Neurobiol Aging; 2009 Mar; 30(3):498-500. PubMed ID: 17716786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both plasma retinol-binding protein and haptoglobin precursor allele 1 in CSF: candidate biomarkers for the progression of normal to mild cognitive impairment to Alzheimer's disease.
    Jung SM; Lee K; Lee JW; Namkoong H; Kim HK; Kim S; Na HR; Ha SA; Kim JR; Ko J; Kim JW
    Neurosci Lett; 2008 May; 436(2):153-7. PubMed ID: 18378077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous CSF drainage in AD: results of a double-blind, randomized, placebo-controlled study.
    Silverberg GD; Mayo M; Saul T; Fellmann J; Carvalho J; McGuire D
    Neurology; 2008 Jul; 71(3):202-9. PubMed ID: 18525029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF biomarkers predict rate of cognitive decline in Alzheimer disease.
    Kester MI; van der Vlies AE; Blankenstein MA; Pijnenburg YA; van Elk EJ; Scheltens P; van der Flier WM
    Neurology; 2009 Oct; 73(17):1353-8. PubMed ID: 19858456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease.
    Montine TJ; Markesbery WR; Morrow JD; Roberts LJ
    Ann Neurol; 1998 Sep; 44(3):410-3. PubMed ID: 9749613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transthyretin as a potential CSF biomarker for Alzheimer's disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors.
    Schultz K; Nilsson K; Nielsen JE; Lindquist SG; Hjermind LE; Andersen BB; Wallin A; Nilsson C; Petersén A
    Eur J Neurol; 2010 Mar; 17(3):456-60. PubMed ID: 19922456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's disease.
    Verwey NA; Schuitemaker A; van der Flier WM; Mulder SD; Mulder C; Hack CE; Scheltens P; Blankenstein MA; Veerhuis R
    Dement Geriatr Cogn Disord; 2008; 26(6):522-7. PubMed ID: 19052452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative EEG in progressing vs stable mild cognitive impairment (MCI): results of a 1-year follow-up study.
    Luckhaus C; Grass-Kapanke B; Blaeser I; Ihl R; Supprian T; Winterer G; Zielasek J; Brinkmeyer J
    Int J Geriatr Psychiatry; 2008 Nov; 23(11):1148-55. PubMed ID: 18537220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human serum transthyretin levels correlate inversely with Alzheimer's disease.
    Han SH; Jung ES; Sohn JH; Hong HJ; Hong HS; Kim JW; Na DL; Kim M; Kim H; Ha HJ; Kim YH; Huh N; Jung MW; Mook-Jung I
    J Alzheimers Dis; 2011; 25(1):77-84. PubMed ID: 21335655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-site amyloid precursor protein cleaving enzyme 1 (BACE1) as a biological candidate marker of Alzheimer's disease.
    Hampel H; Shen Y
    Scand J Clin Lab Invest; 2009; 69(1):8-12. PubMed ID: 18609117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF biomarkers in relationship to cognitive profiles in Alzheimer disease.
    van der Vlies AE; Verwey NA; Bouwman FH; Blankenstein MA; Klein M; Scheltens P; van der Flier WM
    Neurology; 2009 Mar; 72(12):1056-61. PubMed ID: 19307538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease.
    Finehout EJ; Franck Z; Choe LH; Relkin N; Lee KH
    Ann Neurol; 2007 Feb; 61(2):120-9. PubMed ID: 17167789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?
    Palumbo B; Siepi D; Sabalich I; Tranfaglia C; Parnetti L
    Funct Neurol; 2008; 23(2):93-6. PubMed ID: 18671910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usability of cerebrospinal fluid biomarkers in a tertiary memory clinic.
    Brandt C; Bahl JC; Heegaard NH; Waldemar G; Johannsen P
    Dement Geriatr Cogn Disord; 2008; 25(6):553-8. PubMed ID: 18536519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.